Continuous renal replacement therapy with oXiris® in patients with hematologically malignant septic shock: A retrospective study

Figure 3 Trends in the changes in the heart rate, norepinephrine dose, Sequential Organ Failure Assessment score, and lactic acid in the two groups. A: Trends in the changes in the heart rate in the two groups; B: Trends in the changes in the norepinephrine dose in the two groups; C: Trends in the changes in the Sequential Organ Failure Assessment score in the two groups; D: Trends in the changes in the lactic acid in the two groups. oXiris^® group (n = 26), control group (n = 19). Asterisks and circles indicate outliers; ^cIndicates a statistically significant difference compared with control group (P < 0.05); ^dIndicates a statistically significant difference compared with d0 in the oXiris^® group (P < 0.05).